secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANGOCEUTICALS, INC. (MGRX)
CIK:        0001938046
Form:       8-K
Filed at:   2025-04-17T23:59:59+00:00
Accession:  0001641172-25-005263
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mangoceuticals sells $100K Series B preferred, borrows $500K at 18% from Indigo Capital
--------------------------------------------------------------------------------

- Sold 100 shares of Series B Convertible Preferred at $100K; stated value $1,100/share, convertible at $1.50 into up to 73,333 common shares.
- Purchaser granted right to participate in any subsequent financing for 18 months from closing.
- Borrowed $500K from Indigo Capital LP via Promissory Note at 18% annual interest compounded monthly, maturing April 15, 2026.
- Prepayment premium equals interest to stated maturity; mandatory prepayment on qualified financing; default triggers acceleration and additional interest.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938046/000164117225005263/0001641172-25-005263-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938046/000164117225005263/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-005263

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer